BGICC-Breast Gynecological and Immunooncology International Cancer Conference/Facebook
Jan 9, 2025, 14:29
Immuno-Oncology Course at the 17th BGICC
BGICC-Breast Gynecological and Immunooncology International Cancer Conference shared a post on Facebook:
“Announcing the Immuno-Oncology Course at the 17th BGICC!
We’re excited to invite you to the Immuno-Oncology Course, where the latest advancements in cancer treatment and precision medicine will take center stage.
Main Topics Covered:
- World’s first ovarian cancer vaccine
- ESR1 mutation assessment in MBC
- Immunotherapy use in luminal breast cancer
- Immunotherapy in pT1c TNBC
- ADCs sequencing in breast cancer
- Novel Combinations for BRCA positive breast cancer
- HER2 ultralow breast cancer
Dates: 23–24 January 2025
Venue: Hilton Cairo Heliopolis
This course is a must-attend for oncology professionals, researchers, and healthcare providers eager to stay ahead in the ever-evolving field of immuno-oncology.
Register now to secure your spot!
Proceed to the video attached to the post.
More posts featuring BGICC.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 7, 2025, 15:47
Sep 7, 2025, 15:37
Sep 7, 2025, 15:24
Sep 7, 2025, 14:57
Sep 7, 2025, 14:41
Sep 7, 2025, 14:23